Abstract:It has been well known that WT1 gene is overexpressed in leukemia cells regardless subtypes comparing to normal hematopoietic cells. The precise effect of WT1, whether an oncogenic or tumor suppressive effect, in leukemogenesis remains controversial. Isoforms of WT1 protein products caused by alternative splicing may exert different biological function. To investigate the role of WT1 product composed of four major isoforms in certain ratios in hematopoietic cells, we have established a leukemia cell line NB4 which stably expressed exogenous WT1 gene isoforms, then studied their effects on cell biologic behaviors including proliferation, apoptosis and differentiation and its possible molecular mechanisms. The eukaryotic expression recombinant vectors (pCB6+/WT1) containing 4 clones of full-length human WT1 isoforms (WTA: −17aa/-KTS, WTB:+17aa/-KTS, WTC: −17aa/+KTS, WTD: +17aa/+KTS) cDNA were transduced into the leukemia cell line NB4 by electroporation.The positive stable cell clones (NB4/WT1) were obtained. The integration and expresion of WT1 gene isoforms in NB4 cells were confirmed by PCR. RT-PCR and western blotting. We then mainly concentrated on the effect of WT1 isoform WTA (−17aa/-KTS) since this transgene will markedly change the WT1 isoform ratio in NB4 cells from +17aa/+KTS dominant to −17aa/-KTS dominant. The proliferation ability was measured by trypan blue exclusion assay, MTT assay, colony forming assay and cell cycles analysis. Morphology, NBT reduction and CD11b expression were examined to access the cell differentiation. AnnexinV binding tested by FCM and agarose gel electrophoresis were performed to access the susceptibility to action of apoptosis inducing agents. Expressions of PML/RARα, RbAP46, P21, P53, Bcl-2, Bcl-XL and C-myc genes in NB4/WTA cells were determined by semi-quantitative RT-PCR DNA microarray was used to explore the alteration of gene expression profiles in NB4/WTA cells. The proliferation rate of NB4/WTA significantly decreased as measured by growth curves and colony forming ability, while the NB4/WTA cells arrested in S stage increased. NB4/WTA cells treated with ATRA 0.5μM for 2 days were induce to partially differentiate compared to a much higher morphological differentiation rate and CD11b expression level in the negative control cells in same condition. After exposure to As2O3 at 0.8μM for 48 hours, the NB4/WTA cells,but not the control cells, exhibited features of apoptosis RT-PCR have showed increasing level of PML/RARα, RbAP46, P21 and C-myc gene expression, a decreased level of Bcl-2 and a relative constant expression of P53,Bcl-XL, VEGF, CyclinD1 and CyclinD2 in NB4/WTA cells. The gene expression profiles were found changed in transfected NB4 cells. 89 of 4096(2.17%) genes were found to have a differential expression pattern, most of which (nearly 88.7%) were down-regulated. Our results indicated that overexpression of exogenous WT1 isoform (−17aa/-KTS) gene inhibited the proliferation of leukemia cells by delaying the progression of S into G2/M stage in cell cycle and inducing cell apoptosis by down-regulating the Bcl-2 gene expression. WTA gene could also partially inhibit the differentiation of NB4 cells. The introduction and expression of exogenous WT1 isoform gene can change the gene expression profiles in NB4 cells, leading to inhibition of cell growth, retardation of differentiation and more sensitive to apoptosis inducing agents.

Inhibitory Effect of WT1 Gene Isoform Transfection on Proliferation of Leukemia Cell Line NB4

Study on the Biological Functions of WT1 Gene Isoforms in Leukemia Cells.

Effects of WT1 gene isoform transfection on gene expression profiles in leukemia cell line NB4

The Effect of WT1 Expression on the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia

[The influence of different WT1 gene isoforms expression pattern on the differentiation of leukemia cell line NB4].

Experimental Study on Apoptosis of Leukemia Cell Line NB4 Transfected with WT1 Gene

Transfection of WT1 gene isoforms and establishment of leukemia cell lines stably overexpressing WT1 gene

Role of the Wilms' Tumor 1 Gene in the Aberrant Biological Behavior of Leukemic Cells and the Related Mechanisms.

Expression pattern of Wilms' tumor gene WT1 (17AA+) isoform in leukemia

Growth Inhibition of Leukemic Cells by Wilm Tumor Gene (WT1) Antisense Oligodeoxynucleotides

Elimination of Leukemic CD34 + Progenitor Cells by Using Cytotoxic T Lymphocytes Specifically Targeting WT1-derived Peptide: an Experimental Study in Vitro

Detection of WT1 Gene Isoform Expression During Induction of Differentiation of NB4 Cell Line

WT1 gene expression difference in leukemia and non-leukemia and its clinical significance]

Expressions of Wilms Tumor Gene 1 and Isoform WT1(17AA+) in Children with Acute Myeloid Leukemia and Their Clinical Significance

Prognostic significance of Wilms' tumor gene 1 expression in children with B-cell precursor acute lymphoblastic leukemia

The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism

Changes in Expression of WT1 Isoforms During Induced Differentiation of the NB4 Cell Line.

Establishment of the Wilms' tumor gene 1 low and over-expression models in breast cancer cells

WT1 inhibits AML cell proliferation in a p53-dependent manner

[Expression of WT1 Gene in Children with Acute Myeloid Leukemia].

Expression of WT1 gene in myeloproliferative disorders and its clinical significance